Search





Search





Markets
/
Stocks
/
algs
/

Aligos Therapeutics Inc

ALGS

Add to Watchlist

4.230USD

-0.090-2.08%

Close 07-31 16:00（ET）Quotes delayed by 15 min

26.18MMarket Cap

LossP/E TTM

Aligos Therapeutics Inc

4.230

-0.090-2.08%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

ALGS Cash Flow Statement

You can access the annual and quarterly cash flow statements of Aligos Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q2

FY2020Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-10.61%-23.13M

-18.16%-21.75M

-21.11%-24.34M

20.46%-15.50M

8.08%-20.91M

18.78%-18.40M

1.16%-20.10M

-43.16%-19.49M

-1.60%-22.75M

-35.01%-22.66M

-18.67%-20.34M

45.61%-13.62M

-9.56%-22.39M

55.22%-16.78M

32.45%-17.14M

-8.76%-25.04M

31.42%-20.43M

-90.41%-37.48M

---25.37M

-30.09%-23.02M

-46.64%-29.80M

---19.68M

---17.69M

---20.32M

Net income from continuing operations

-153.47%-23.04M

75.80%-19.88M

-63.75%-31.54M

-413.44%-15.86M

223.59%43.09M

-194.53%-82.15M

-6.75%-19.26M

126.93%5.06M

-51.88%-34.86M

-27.44%-27.89M

3.11%-18.04M

5.69%-18.79M

35.55%-22.95M

41.97%-21.89M

43.79%-18.62M

33.18%-19.92M

-28.69%-35.62M

-9.57%-37.71M

---33.13M

-43.38%-29.82M

-38.17%-27.67M

---34.42M

---20.80M

---20.03M

Operating gains losses

78.35%346.00K

6.64%257.00K

-11.29%220.00K

1.17%259.00K

-31.21%194.00K

-38.83%241.00K

-19.22%248.00K

-77.30%256.00K

-37.89%282.00K

-24.52%394.00K

-42.94%307.00K

97.89%1.13M

-32.84%454.00K

-28.30%522.00K

-31.03%538.00K

-25.97%570.00K

-8.77%676.00K

-0.27%728.00K

--780.00K

-19.71%770.00K

123.87%741.00K

--730.00K

--959.00K

--331.00K

Other non-cash items

-49.72%90.00K

-17.24%48.00K

-314.29%-232.00K

38.15%-308.00K

-41.88%179.00K

-84.78%58.00K

-114.97%-56.00K

-339.42%-498.00K

150.41%308.00K

27.00%381.00K

25.08%374.00K

-29.49%208.00K

-61.08%123.00K

-2.60%300.00K

58.20%299.00K

64.80%295.00K

86.98%316.00K

49.51%308.00K

--189.00K

616.00%179.00K

628.13%169.00K

--206.00K

--25.00K

---32.00K

Change in working capital

140.60%1.56M

-518.97%-2.41M

148.15%1.53M

-77.38%930.00K

30.20%-3.83M

-33.11%-390.00K

48.69%-3.18M

539.35%4.11M

-49.58%-5.49M

-133.87%-293.00K

-118.07%-6.20M

106.45%643.00K

-135.31%-3.67M

119.43%865.00K

-189.21%-2.84M

-515.32%-9.98M

279.73%10.40M

-135.63%-4.45M

--3.19M

20.64%2.40M

-392.60%-5.79M

--12.50M

--1.99M

---1.18M

-Change in other current assets

316.33%318.00K

-130.07%-681.00K

245.29%587.00K

144.20%337.00K

-172.06%-147.00K

74.81%-296.00K

121.82%170.00K

-93.63%138.00K

-90.22%204.00K

-105.06%-1.18M

-236.19%-779.00K

9.62%2.17M

-37.58%2.09M

92.67%-573.00K

1605.26%572.00K

496.59%1.98M

1106.50%3.34M

-155.49%-7.81M

---38.00K

-333.80%-498.00K

135.65%277.00K

---3.06M

--213.00K

---777.00K

-Change in other current liabilities

68.87%-47.00K

66.67%-168.00K

38.75%-411.00K

-4.30%579.00K

74.28%-151.00K

80.93%-504.00K

77.98%-671.00K

896.05%605.00K

74.73%-587.00K

-16.38%-2.64M

25.77%-3.05M

97.94%-76.00K

-118.68%-2.32M

-353.29%-2.27M

-167.25%-4.11M

-138.94%-3.69M

1318.32%12.44M

-104.17%-501.00K

---1.54M

---1.55M

---1.02M

--12.00M

----

--0.00

Cash from non-recurring investing activities

Cash from operating activities

-10.61%-23.13M

-18.16%-21.75M

-21.11%-24.34M

20.46%-15.50M

8.08%-20.91M

18.78%-18.40M

1.16%-20.10M

-43.16%-19.49M

-1.60%-22.75M

-35.01%-22.66M

-18.67%-20.34M

45.61%-13.62M

-9.56%-22.39M

55.22%-16.78M

32.45%-17.14M

-8.76%-25.04M

31.42%-20.43M

-90.41%-37.48M

---25.37M

-30.09%-23.02M

-46.64%-29.80M

---19.68M

---17.69M

---20.32M

Investing cash flow

Net cash from continuing investing activities

60.47%69.00K

228.57%92.00K

642.31%193.00K

1457.14%109.00K

-37.68%43.00K

300.00%28.00K

36.84%26.00K

150.00%7.00K

885.71%69.00K

-92.31%7.00K

533.33%19.00K

-104.19%-14.00K

-98.64%7.00K

-72.92%91.00K

-96.91%3.00K

119.74%334.00K

67.75%515.00K

450.82%336.00K

--97.00K

-73.29%152.00K

-71.83%307.00K

--61.00K

--569.00K

--1.09M

Capital expenditures

60.47%69.00K

228.57%92.00K

642.31%193.00K

1457.14%109.00K

-37.68%43.00K

300.00%28.00K

36.84%26.00K

--7.00K

885.71%69.00K

-92.31%7.00K

533.33%19.00K

----

-98.64%7.00K

-72.92%91.00K

-96.91%3.00K

119.74%334.00K

67.75%515.00K

450.82%336.00K

--97.00K

-73.29%152.00K

-71.83%307.00K

--61.00K

--569.00K

--1.09M

Net cash flow from disposal of fixed assets

60.47%69.00K

228.57%92.00K

642.31%193.00K

1457.14%109.00K

-37.68%43.00K

300.00%28.00K

36.84%26.00K

150.00%7.00K

885.71%69.00K

-92.31%7.00K

533.33%19.00K

-104.19%-14.00K

-98.64%7.00K

-72.92%91.00K

-96.91%3.00K

119.74%334.00K

67.75%515.00K

450.82%336.00K

--97.00K

-73.29%152.00K

-71.83%307.00K

--61.00K

--569.00K

--1.09M

Net cash flow from investment products

179.50%35.00M

-109.64%-1.93M

359.29%47.88M

-198.28%-39.31M

50.30%-44.02M

--20.00M

104140.00%10.42M

60.06%40.00M

-542.87%-88.57M

-100.00%0.00

-99.97%10.00K

359.18%24.99M

133.40%20.00M

172.45%11.70M

56892.98%32.49M

-196.42%-9.64M

-698.89%-59.89M

-207.63%-16.14M

--57.00K

-35.48%10.00M

144.09%10.00M

--15.00M

--15.50M

---22.68M

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

179.27%34.93M

-110.12%-2.02M

358.58%47.68M

-198.57%-39.42M

50.29%-44.07M

285414.29%19.97M

115633.33%10.40M

59.95%39.99M

-543.37%-88.64M

-100.06%-7.00K

-100.03%-9.00K

350.64%25.00M

133.10%19.99M

170.42%11.60M

81307.50%32.48M

-201.30%-9.98M

-723.17%-60.40M

-210.32%-16.48M

---40.00K

-34.04%9.85M

140.78%9.69M

--14.94M

--14.93M

---23.77M

Financing cash flow

Cash flow from continuous financing activities

-100.06%-62.00K

26.80%123.00K

-1225.00%-53.00K

-162.99%-177.00K

535584.21%101.74M

-99.89%97.00K

80.95%-4.00K

-32.13%281.00K

-1800.00%-19.00K

72574.38%87.94M

-10.53%-21.00K

398.80%414.00K

95.24%-1.00K

-78.08%121.00K

-100.02%-19.00K

-12.63%83.00K

-126.92%-21.00K

-99.71%552.00K

--77.95M

251.85%95.00K

262.50%78.00K

--193.32M

--27.00K

---48.00K

Net cash flow from debt Issuance/repayment

---62.00K

93.02%-3.00K

-100.00%-10.00K

----

-975.00%-43.00K

76.19%-5.00K

65.96%-16.00K

20.83%-19.00K

-114.81%-4.00K

25.00%-21.00K

-62.07%-47.00K

22.58%-24.00K

235.00%27.00K

-27.27%-28.00K

-52.63%-29.00K

-72.22%-31.00K

94.48%-20.00K

---22.00K

-105.71%-19.00K

-63.64%-18.00K

---362.00K

--333.00K

---11.00K

Net cash flow from common stock issuance/repurchase

----

-10.00%126.00K

---43.00K

----

--101.74M

-99.20%140.00K

--0.00

-35.57%297.00K

----

18552.13%17.53M

--0.00

315.32%461.00K

----

--94.00K

-100.00%0.00

--111.00K

----

-100.00%0.00

--78.58M

----

--155.54M

--62.00K

----

Net cash flow from preferred stock issuance/repurchase

----

--70.41M

----

-100.00%0.00

--0.00

----

100.00%0.00

--41.13M

--0.00

---55.00K

Proceeds from stock option exercised by employees

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

130.00%23.00K

-100.00%0.00

-50.00%9.00K

-99.53%1.00K

-89.58%10.00K

1042.86%720.00K

--18.00K

--213.00K

433.33%96.00K

--63.00K

----

--18.00K

Net cash flow from other financing activities

--0.00

-4400.00%-43.00K

----

--1.00K

----

100.00%0.00

----

95.15%-148.00K

---628.00K

73.10%-99.00K

--0.00

---3.05M

---368.00K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

-100.06%-62.00K

26.80%123.00K

-1225.00%-53.00K

-162.99%-177.00K

535584.21%101.74M

-99.89%97.00K

80.95%-4.00K

-32.13%281.00K

-1800.00%-19.00K

72574.38%87.94M

-10.53%-21.00K

398.80%414.00K

95.24%-1.00K

-78.08%121.00K

-100.02%-19.00K

-12.63%83.00K

-126.92%-21.00K

-99.71%552.00K

--77.95M

251.85%95.00K

262.50%78.00K

--193.32M

--27.00K

---48.00K

Net cash flow

Beginning cash balance

-50.38%18.41M

18.66%42.06M

-58.42%18.77M

203.17%73.87M

-72.67%37.11M

-49.73%35.44M

-50.32%45.15M

-69.18%24.37M

66.67%135.77M

-18.51%70.50M

27.64%90.87M

-25.49%79.07M

-56.43%81.46M

-64.01%86.52M

-62.10%71.19M

-47.18%106.12M

-15.37%186.98M

642.58%240.39M

--187.84M

673.74%200.92M

215.17%220.94M

--32.37M

--25.97M

--70.10M

Current period cash flow changes

-68.07%11.74M

-1519.15%-23.64M

339.88%23.29M

-365.16%-55.10M

133.00%36.77M

-97.45%1.67M

52.34%-9.71M

76.08%20.78M

-4551.65%-111.41M

1390.45%65.27M

-232.88%-20.37M

133.79%11.80M

97.04%-2.40M

90.53%-5.06M

-70.83%15.33M

-167.14%-34.93M

-303.79%-80.86M

-128.32%-53.41M

--52.54M

-377.89%-13.07M

54.63%-20.02M

--188.57M

---2.74M

---44.14M

Ending cash balance

-59.18%30.15M

-50.38%18.41M

18.66%42.06M

-58.42%18.77M

203.17%73.87M

-72.67%37.11M

-49.73%35.44M

-50.32%45.15M

-69.18%24.37M

66.67%135.77M

-18.51%70.50M

27.64%90.87M

-25.49%79.07M

-56.43%81.46M

-64.01%86.52M

-62.10%71.19M

-47.18%106.12M

-15.37%186.98M

--240.39M

708.59%187.84M

673.74%200.92M

--220.94M

--23.23M

--25.97M

Free cash flow

-10.71%-23.20M

-18.48%-21.84M

-21.92%-24.54M

19.93%-15.61M

8.17%-20.95M

18.68%-18.43M

1.12%-20.13M

-43.21%-19.50M

-1.88%-22.82M

-34.32%-22.66M

-18.76%-20.36M

46.33%-13.62M

-6.90%-22.39M

55.38%-16.87M

32.69%-17.14M

-9.49%-25.37M

30.41%-20.95M

-91.52%-37.82M

---25.46M

-26.87%-23.17M

-40.61%-30.10M

---19.75M

---18.26M

---21.41M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Aligos Therapeutics Inc Generate?



Aligos Therapeutics Inc generated -82.50M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Aligos Therapeutics Inc's Operating Cash Flow Change Year Over Year?



Aligos Therapeutics Inc's operating cash flow increased by -2.18% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Aligos Therapeutics Inc Spend on Capital Expenditures?



Aligos Therapeutics Inc spent 437.00K on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Aligos Therapeutics Inc's Financing Cash Flow Changed?



Aligos Therapeutics Inc used 101.64M in financing activities in the latest quarter.

What is free cash flow and why does it matter for ALGS?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Aligos Therapeutics Inc’s free cash flow in the latest quarter?



Free cash flow was -82.94M reflecting a -2.56% change from the previous year.